South Shore Capital Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.46M Sell
13,605
-144
-1% -$33.6K 2.31% 11
2026
Q1
$3.36M Buy
13,749
+48
+0.4% +$11.2K 2.46% 8
2025
Q4
$2.84M Buy
+13,701
New +$2.71M 2.07% 11
2022
Q3
$1.92M Buy
11,772
+129
+1% +$21.8K 4.48% 4
2022
Q2
$2.07M Sell
11,643
-488
-4% -$86.9K 4.32% 4
2022
Q1
$2.15M Buy
12,131
+2,695
+29% +$459K 3.5% 4
2021
Q4
$1.61M Buy
9,436
+620
+7% +$102K 2.63% 5
2021
Q3
$1.42M Sell
8,816
-1
-0% -$171 2.58% 7
2021
Q2
$1.45M Buy
8,817
+368
+4% +$60.9K 2.57% 7
2021
Q1
$1.39M Sell
8,449
-2,267
-21% -$367K 1.38% 15
2020
Q4
$1.69M Buy
+10,716
New +$1.58M 1.67% 13

Other funds holding JNJ

South Shore Capital Advisors's JNJ Position: Q2 2026 in Review

South Shore Capital Advisors reduced its Johnson & Johnson (JNJ) stake by 1% in Q2 2026, selling an estimated $33.6K and leaving 13,605 shares worth $3.46M. The position accounts for 2.31% of the portfolio, ranked #11.

South Shore Capital Advisors first reported a position in JNJ in Q4 2020 and has held it in 11 quarters since. 4,685 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • South Shore Capital Advisors held 13,605 shares of Johnson & Johnson worth $3.46M as of Q2 2026.
  • South Shore Capital Advisors sold 144 Johnson & Johnson shares in Q2 2026, an estimated $33.6K.
  • Johnson & Johnson made up 2.31% of South Shore Capital Advisors's portfolio in Q2 2026, its #11 holding.
  • South Shore Capital Advisors first reported a position in Johnson & Johnson in Q4 2020 and has held it in 11 quarters since.
  • 4,685 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on South Shore Capital Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.